Abstract
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Highlights
Measures of glomerular filtration rate (GFR) showed discordant results
CKD-EPI creatinine formula resulted more accurate than other equations in subjects with normal or mildly decreased renal function in the general population and cystatin C could be even a more sensitive measure
As for lipids, lipoprotein subfractions were suggested to be more informative on the cardiovascular risk than the commonly used cholesterol subfractions, with protection conferred especially by HDLp-small (Baker et al JID 2010)
Summary
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial). I Izzo1*, L Albini, A Calabresi, D Motta, R Bellagamba, R Fezza, P Narciso, L Sighinolfi, P Maggi, E Focà, M Mendeni, L Manili, M Magoni, G Carosi, E Quiros-Roldan, C Torti. From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. From Tenth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 7-11 November 2010
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
